People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardium Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $750K | $41.4M | 2009 |
Tyler M. Dylan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tyler M. Dylan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerald J. Lewis | 1 | 2 |
| Murray H Hutchison | 1 | 2 |
| Andrew M. Leitch | 1 | 2 |
| Dennis M. Mulroy | 1 | 1 |
| Ronald I. Simon | 1 | 1 |
| Edward W. Gabrielson | 1 | 1 |
| Lon E. Otremba | 1 | 1 |
| Christopher J. Reinhard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.